Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00495235 · ClinicalTrials.gov registry record
Study of Insulin Resistance and Endometrial Cancer in Harris County, Texas
A clinical trial, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- 147
- Enrollment target
NCT00495235: Completed study, sponsored by M.D. Anderson Cancer Center.
NCT00495235 is a clinical trial that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 147 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00495235 has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- 147 participants
- Enrollment target
Study Summary
The goal of this clinical research study is to find out if there is a link between insulin resistance (or pre-diabetes) and endometrial cancer. Primary Objective: 1\. To determine the association between insulin resistance and endometrial cancer in women in Harris County, Texas. 2. To assess the effect of body mass index (BMI) on the association between insulin resistance and endometrial cancer. Secondary Objectives: 1. To explore the association between polycystic ovarian syndrome (PCOS) and endometrial cancer. 2. To assess the relationship between known reproductive risk factors, menstrual risk factors, family history and endometrial cancer. 3. To explore the molecular changes associated with insulin resistance and PCOS on normal endometrium and tumor tissue.
Interventions
- BEHAVIORAL Questionnaire
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 147 participants |
| Start Date | 2005-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00495235
The ClinicalTrials.gov registry entry for NCT00495235 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 147 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Questionnaire is the first listed.
NCT00495235 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00495235 about?
NCT00495235 is a clinical study titled "Study of Insulin Resistance and Endometrial Cancer in Harris County, Texas". The goal of this clinical research study is to find out if there is a link between insulin resistance (or pre-diabetes) and endometrial cancer. Primary Objective: 1\. To determine the association between insulin resistance and endometrial cancer in women in Harris County, Texas. 2. To assess the e...
What is the current status of trial NCT00495235?
This trial is currently completed. The enrollment target is 147 participants. The study started on 2005-10.
What interventions are being tested in trial NCT00495235?
The interventions under investigation include: Questionnaire (BEHAVIORAL).
Who is sponsoring clinical trial NCT00495235?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.